EnBio Holdings, Inc (TYO:6092)
782.00
-18.00 (-2.25%)
May 28, 2026, 1:29 PM JST
EnBio Holdings Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 4,036 | 3,293 | 3,604 | 2,828 | 2,371 |
Cash & Short-Term Investments | 4,036 | 3,293 | 3,604 | 2,828 | 2,371 |
Cash Growth | 22.56% | -8.63% | 27.44% | 19.28% | 17.67% |
Receivables | 2,309 | 2,354 | 1,270 | 792 | 1,593 |
Inventory | 4,445 | 2,952 | 2,889 | 3,373 | 1,849 |
Other Current Assets | 619 | 358 | 483 | 325 | 645 |
Total Current Assets | 11,409 | 8,957 | 8,246 | 7,318 | 6,458 |
Property, Plant & Equipment | 8,771 | 8,827 | 7,918 | 7,016 | 7,914 |
Long-Term Investments | 329 | 1,403 | 1,375 | 1,186 | 1,221 |
Goodwill | 86 | 94 | 102 | 110 | 118 |
Other Intangible Assets | 331 | 351 | 373 | 399 | 427 |
Other Long-Term Assets | 2 | 2 | 1 | 1 | 2 |
Total Assets | 22,848 | 21,195 | 19,310 | 17,349 | 16,370 |
Accounts Payable | 1,306 | 855 | 1,098 | 485 | 693 |
Accrued Expenses | 65 | 41 | 36 | 31 | 50 |
Short-Term Debt | 972 | 1,788 | 1,088 | 854 | 645 |
Current Portion of Long-Term Debt | 1,915 | 1,666 | 1,300 | 2,293 | 1,276 |
Current Income Taxes Payable | 553 | 199 | 183 | 316 | 315 |
Other Current Liabilities | 371 | 269 | 439 | 492 | 467 |
Total Current Liabilities | 5,182 | 4,818 | 4,144 | 4,471 | 3,446 |
Long-Term Debt | 7,766 | 6,643 | 6,230 | 5,749 | 6,660 |
Other Long-Term Liabilities | 575 | 504 | 347 | 273 | 290 |
Total Liabilities | 13,523 | 11,965 | 10,721 | 10,493 | 10,396 |
Common Stock | 2,325 | 2,325 | 2,325 | 1,797 | 1,797 |
Additional Paid-In Capital | 2,412 | 2,404 | 2,405 | 1,876 | 1,876 |
Retained Earnings | 4,341 | 4,149 | 3,761 | 3,111 | 2,352 |
Treasury Stock | -35 | -38 | -15 | -15 | -15 |
Comprehensive Income & Other | 204 | 301 | 17 | 18 | -121 |
Total Common Equity | 9,247 | 9,141 | 8,493 | 6,787 | 5,889 |
Minority Interest | 78 | 89 | 96 | 69 | 85 |
Shareholders' Equity | 9,325 | 9,230 | 8,589 | 6,856 | 5,974 |
Total Liabilities & Equity | 22,848 | 21,195 | 19,310 | 17,349 | 16,370 |
Total Debt | 10,653 | 10,097 | 8,618 | 8,896 | 8,581 |
Net Cash (Debt) | -6,617 | -6,804 | -5,014 | -6,068 | -6,210 |
Net Cash Per Share | -816.34 | -840.11 | -628.52 | -913.63 | -934.94 |
Filing Date Shares Outstanding | 8.12 | 8.1 | 8.14 | 8.14 | 6.64 |
Total Common Shares Outstanding | 8.12 | 8.1 | 8.14 | 6.64 | 6.64 |
Working Capital | 6,227 | 4,139 | 4,102 | 2,847 | 3,012 |
Book Value Per Share | 1139.16 | 1128.50 | 1043.71 | 1022.55 | 886.25 |
Tangible Book Value | 8,830 | 8,696 | 8,018 | 6,278 | 5,344 |
Tangible Book Value Per Share | 1087.79 | 1073.57 | 985.33 | 945.86 | 804.23 |
Order Backlog | - | 2,942 | 3,624 | 2,912 | 1,514 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.